Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays.

@article{Haaf2014RiskSI,
  title={Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays.},
  author={Philip Haaf and Tobias Reichlin and Raphael Twerenbold and Rebeca Hoeller and Mar{\'i}a Rubini Gim{\'e}nez and Christa Zellweger and Berit Moehring and Catherine G Fischer and Bernadette Meller and Karin Wildi and Michael Freese and Claudia Stelzig and Tamina Mosimann and Miriam Reiter and Mira Mueller and Thomas Hochgruber and Seoung Mann Sou and Karsten Murray and Jan Minners and Heike Freidank and Stefan O\sswald and Christian M{\"u}ller},
  journal={European heart journal},
  year={2014},
  volume={35 6},
  pages={365-75}
}
AIMS Several high-sensitivity cardiac troponin (hs-cTn) assays have recently been developed. It is unknown which hs-cTn provides the most accurate prognostic information and to what extent early changes in hs-cTn predict mortality. METHODS AND RESULTS In a prospective, international multicentre study, cTn was simultaneously measured with three novel [high-sensitivity cardiac Troponin T (hs-cTnT), Roche Diagnostics; hs-cTnI, Beckman-Coulter; hs-cTnI, Siemens] and a conventional assay (cTnT… CONTINUE READING